Chaperone Assisted Crystallography
Chaperone Assisted Crystallography
批准号:
7932648
负责人:
ANTHONY A KOSSIAKOFF
金额:
$28.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31
关键词:
AchievementAdrenergic ReceptorAntibodiesArrestinsBindingBinding ProteinsBiochemistryBiological ModelsBiologyCategoriesCell physiologyCollaborationsCommunitiesComplexCrystallizationCrystallographyDNA-Protein InteractionDevelopmentDiseaseEffectivenessEngineeringExtramural ActivitiesF-ActinFamilyFoundationsFruitFunctional RNAGenerationsGenetic CodeGoalsGuidelinesHIV-1 integraseHeterogeneityHuman ResourcesImmunoglobulin FragmentsIntegral Membrane ProteinIntronsLengthLibrariesMacromolecular ComplexesMembrane ProteinsMetalsMethodologyMethodsMolecularMolecular ChaperonesMolecular ConformationNucleic AcidsPhage DisplayPhasePlatelet Factor 4Potassium ChannelProbabilityProteinsRNAReagentResearch PersonnelScreening procedureSolutionsStructural BiologistStructureSurfaceSurface PropertiesSystemTechnologyWorkactivating transcription factorbasebiological researchcombinatorialdesigndesigner antibodydrug developmentexperienceimprovedinnovationinsightoutreach programprogramsprotein complexprotein structurepublic health relevancereceptorscaffoldstructural biologysuccesstranscription factorvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We have developed and validated a powerful high throughput approach called "Chaperone-Assisted Crystallography" (CAC) that can greatly facilitate solving the most challenging types of structural biology problems. The long-range goal is to develop the CAC platform to a level where its application will have a transforming effect on the structural biology community by making difficult problems routine and "impossible" problems feasible. The CAC methodology is based on the use of synthetically derived antibody fragments as "crystallization chaperones" that specifically and tightly bind to a target protein or RNA entity and thereby promote crystallization and provide phasing information. The technical breakthrough that forms the foundation of the CAC method is an innovative combinatorial library design that employs a "reduced genetic code" to produce highly functional synthetic antibody fragments to an extraordinary broad spectrum of target molecules. Using this approach we have produced chaperones to recalcitrant targets, including membrane proteins and functional RNAs, facilitating crystallization and subsequent structure determination. Major achievements include the structures of the full-length KcsA potassium ion channel and the P4P6 domain of group 1 intron. To further expand the capabilities of the CAC technology, we propose to develop a number of additional enhancements. The 2nd Generation CAC platform will include: i) new "reduced genetic code" chaperone libraries tailored for membrane proteins and nucleic acids, respectively; ii) trapping preferred conformational states of the targeted molecules; iii) targeting chaperones to a specific, predefined region on the target molecule; iv) the ability to produce chaperones to transient macromolecular complexes (e.g. DNA-protein interactions) and stabilize such complexes. v) "co-chaperones" in the form of Fab-binding proteins that can be engineered to introduce anomalous atom types for MAD phasing and alter surface properties, as well as to induce lattice formation. The effectiveness of the new CAC enhancements will be evaluated against a set of five high-impact structural problems that have proven to be totally intractable using traditional approaches. These "model systems" include: 1) HIV 1 Integrase-DNA complex, 2) F-actin tetramer, 3) MerR family of transcription factors, 4) NaChBac Na+ channel, and 5) conformationally locked forms of the 22-adregenic receptor. Experiences gained from working with these sytems will be used to further refine the CAC technology. To make this powerful technology available to the structural biology community, we have established an extramural program where investigators can send us their recalcitrant proteins to be put through the CAC pipeline, or send personnel to our labs to be supervised on producing crystallization chaperones. PUBLIC HEALTH RELEVANCE: We are developing our Chaperone-Assisted Crystallography (CAC) technology to solve the structure of protein systems of critical biomedical importance that have been recalcitrant to crystallization by traditional methods. A key innovation is our ability to rapidly generate designer antibodies that tightly bind the target molecules and promote the formation of high-quality crystals for x-ray crystallographic analysis. The technology will have a broad impact on the structural biology community and the structures determined with it will advance fundamental understanding of cellular functions and provide guidelines for drug development in a variety of diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chaperone-Assisted Structure Determination of Membrane Proteins
-
批准号:10549305
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2016
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Assisted Structure Determination of Membrane Proteins
-
批准号:10321297
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2016
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Assisted Structure Determination of Membrane Proteins
-
批准号:9887438
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2016
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Assisted Structure Determination of Membrane Proteins
-
批准号:9007806
-
项目类别:
-
资助金额:$34.29万
-
财政年份:2016
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Recombinant Antibody Network
-
批准号:8545885
-
项目类别:
-
资助金额:$180.73万
-
财政年份:2011
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Recombinant Antibody Network
-
批准号:8338454
-
项目类别:
-
资助金额:$316.28万
-
财政年份:2011
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Recombinant Antibody Network
-
批准号:8725993
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Recombinant Antibody Network
-
批准号:8221472
-
项目类别:
-
资助金额:$323.34万
-
财政年份:2011
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Foreign - Univ. of Toronto, PI-Dr. Sachdev Sidhu
-
批准号:8153300
-
项目类别:
-
资助金额:$7.03万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Synthetic Antigen Binder Core
-
批准号:9351543
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Enabled studies of epigenetic regulation enzymes
-
批准号:8730671
-
项目类别:
-
资助金额:$132.14万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Enabled studies of epigenetic regulation enzymes
-
批准号:8152115
-
项目类别:
-
资助金额:$130.25万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Enabled studies of epigenetic regulation enzymes
-
批准号:8546405
-
项目类别:
-
资助金额:$126.96万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Enabled studies of epigenetic regulation enzymes
-
批准号:8306879
-
项目类别:
-
资助金额:$130.94万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Enabled studies of epigenetic regulation enzymes
-
批准号:7982237
-
项目类别:
-
资助金额:$156.08万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone-Enabled studies of epigenetic regulation enzymes
-
批准号:8153269
-
项目类别:
-
资助金额:$136.06万
-
财政年份:2010
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Subproject 2
-
批准号:7091803
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2005
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone Assisted Crystallography
-
批准号:7007244
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2005
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
Chaperone Assisted Crystallography
-
批准号:7581944
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2005
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
X-RAY STUDY OF HORMONE-RECEPTOR AND PROTEIN-ANTIBODY COMPLEXES
-
批准号:7181843
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2005
-
负责人:ANTHONY A KOSSIAKOFF
-
依托单位:
海外基金